| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Aug, 2026 | Aug, 2026 |
| Sales | 0 | 300 | 290 | 0 | 0 |
| Sales Growth | -100.00% | +3.45% | unch | unch | unch |
| Net Income | -1,120 | -2,650 | -4,440 | 0 | 0 |
| Net Income Growth | +57.74% | +40.32% | unch | unch | unch |
Optimi Health Corp (OPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.
Fiscal Year End Date: 12/31